Pay in 4 interest-free payments of $6.37 Learn more
Ships within 48 hours · Estimated delivery Oct 9 - Oct 14
After 72 weeks, about 33% of people on the 7.2 mg dose lost at least 25% of their body weight, compared to about 17% of those taking the 2.4 mg dose
Alexander Kokkinos Georgia Argyrakopoulou Carel Le Roux Theocharis Koufakis MD, PhDs Post Retatrutide is poised to transform the management of obesity owing to its unprecedented efficacy
Retatrutide is therefore not equivalent to Ozempic, Wegovy, Mounjaro, or Zepbound in regulatory or commercial terms
Ultimately, if Ozempic and Mounjaro are consecutively covered, this would represent a significant turning point
US$ 21.41
US$ 26.66
US$ 25.73
